SKI Market

Indian Indices

Sensex

81,537.70 -769.67
( -0.94%)

Global Indices

Nasdaq

49,128.98 -276.04
(-0.56%)

Dow Jones

6,938.97 4.62
(0.07%)

Hang Seng

53,831.56 142.67
(0.27%)

Nikkei 225

10,138.52 -11.53
(-0.11%)

Forex

USD-INR

91.58 0.09
(0.10%)

EUR-INR

107.27 0.14
(0.13%)

GBP-INR

123.20 0.33
(0.27%)

JPY-INR

0.58 0.00
(-0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aarti Drugs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524348

INE767A01016

147.0110661

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AARTIDRUGS

17.77

3383.38

EPS(TTM)

Face Value()

Div & Yield %

20.86

0.27

Back

Valiant Laboratories reports consolidated net profit of Rs 0.20 crore in the September 2025 quarter

Nov 12,2025

Net profit of Valiant Laboratories reported to Rs 0.20 crore in the quarter ended September 2025 as against net loss of Rs 4.74 crore during the previous quarter ended September 2024. Sales rose 115.08% to Rs 46.20 crore in the quarter ended September 2025 as against Rs 21.48 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	46.20	21.48	115
OPM %	0.15	-31.38	-
PBDT	0.81	-3.39	LP
PBT	0.28	-3.91	LP
NP	0.20	-4.74	LP

81,537.70 -769.67 ( -0.94%)

49,128.98 -276.04 (-0.56%)

6,938.97 4.62 (0.07%)

53,831.56 142.67 (0.27%)

10,138.52 -11.53 (-0.11%)

91.58 0.09 (0.10%)

107.27 0.14 (0.13%)

123.20 0.33 (0.27%)

0.58 0.00 (-0.17%)